Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice
Serotonin 1A (5-HT 1A) receptors are involved in anxiety. This study focuses on the role of genetic factors on the anxiety-related effects of 5-HT 1A receptor stimulation using both a within subject design. The effects of 5-HT 1A receptor activation were studied in high- and low-anxiety mice (129S6/...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2004-06, Vol.494 (1), p.45-53 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 53 |
---|---|
container_issue | 1 |
container_start_page | 45 |
container_title | European journal of pharmacology |
container_volume | 494 |
creator | Adriaan Bouwknecht, J van der Gugten, Jan Groenink, Lucianne Olivier, Berend Paylor, Richard E |
description | Serotonin
1A (5-HT
1A) receptors are involved in anxiety. This study focuses on the role of genetic factors on the anxiety-related effects of 5-HT
1A receptor stimulation using both a within subject design. The effects of 5-HT
1A receptor activation were studied in high- and low-anxiety mice (129S6/SvEvTac (S6) and C57BL/6J (B6), respectively) in behavioral and physiological anxiety-related assays. These two strains were also selected because they are frequently used in gene-targeting studies. Mice were treated with the selective 5-HT
1A receptor agonist flesinoxan (0–0.3–1.0–3.0 mg/kg s.c.) and tested in either the open-field activity test, the light–dark exploration test, or the stress-induced hyperthermia paradigm. Flesinoxan unexpectedly increased anxiety, but also decreased activity on several behavioral measures in B6 mice. Flesinoxan produced only minimal effects in the behavioral tests in the high-anxiety S6 strain. In contrast, the physiological hyperthermia response showed anxiolytic-like effects of flesinoxan in both strains. Our data indicate that the role of 5-HT
1A receptor activation on anxiety-related responses is dependent on genetic background and selected paradigm used to assess anxiety. These findings indicate that it is critical to use a multi-level approach to develop mouse models for human diseases. In addition, the implication of such findings for studies on genetically modified mice is discussed. |
doi_str_mv | 10.1016/j.ejphar.2004.04.037 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72025661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299904004443</els_id><sourcerecordid>72025661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-ae439a0c7d9fdbf58fc3dc45a4400b7d66d0a5be64dd123a42805b3963d6eacb3</originalsourceid><addsrcrecordid>eNp9kF2LEzEUhoMobl39ByK50btp8z0TLwS37K5KwYtdr0MmObEpM5OatGX7701tQa-EwzkQnvNy8iD0lpI5JVQtNnPYbNc2zxkhYn4q3j5DM9q1uiEtZc_RjBAqGqa1vkKvStkQQqRm8iW6opJqISSZoXQDa3uIKdsB28nj7fpYYhrSz-jqy5j2BWr3MBQcUq7IU4Td8SOGEMDtCk4BhwFKnNKTnXCcMGX6QS0eDreHR-v-RC5le7NaqG94jA5eoxfBDgXeXOY1-nF3-7j80qy-339dfl41jnfdrrEguLbEtV4H3wfZBce9E9IKQUjfeqU8sbIHJbynjFvBOiJ7rhX3Cqzr-TX6cM7d5vRrD2VnxlgcDIOdoH7KtIwwqRStoDiDLqdSMgSzzXG0-WgoMSfRZmPOos1JtDkVb-vau0v-vh_B_126mK3A-wtgS1UZsp1cLP9wnRRMsMp9OnNVMRwiZFNchMmBj7kaNj7F_1_yG4LQnXs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72025661</pqid></control><display><type>article</type><title>Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Adriaan Bouwknecht, J ; van der Gugten, Jan ; Groenink, Lucianne ; Olivier, Berend ; Paylor, Richard E</creator><creatorcontrib>Adriaan Bouwknecht, J ; van der Gugten, Jan ; Groenink, Lucianne ; Olivier, Berend ; Paylor, Richard E</creatorcontrib><description>Serotonin
1A (5-HT
1A) receptors are involved in anxiety. This study focuses on the role of genetic factors on the anxiety-related effects of 5-HT
1A receptor stimulation using both a within subject design. The effects of 5-HT
1A receptor activation were studied in high- and low-anxiety mice (129S6/SvEvTac (S6) and C57BL/6J (B6), respectively) in behavioral and physiological anxiety-related assays. These two strains were also selected because they are frequently used in gene-targeting studies. Mice were treated with the selective 5-HT
1A receptor agonist flesinoxan (0–0.3–1.0–3.0 mg/kg s.c.) and tested in either the open-field activity test, the light–dark exploration test, or the stress-induced hyperthermia paradigm. Flesinoxan unexpectedly increased anxiety, but also decreased activity on several behavioral measures in B6 mice. Flesinoxan produced only minimal effects in the behavioral tests in the high-anxiety S6 strain. In contrast, the physiological hyperthermia response showed anxiolytic-like effects of flesinoxan in both strains. Our data indicate that the role of 5-HT
1A receptor activation on anxiety-related responses is dependent on genetic background and selected paradigm used to assess anxiety. These findings indicate that it is critical to use a multi-level approach to develop mouse models for human diseases. In addition, the implication of such findings for studies on genetically modified mice is discussed.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2004.04.037</identifier><identifier>PMID: 15194450</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>5-HT 1A receptor ; Animal model ; Animals ; Anxiety ; Anxiety - drug therapy ; Anxiety - genetics ; Behavior ; Biological and medical sciences ; Darkness ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Exploratory Behavior - drug effects ; Exploratory Behavior - physiology ; Flesinoxan ; Lighting ; Male ; Medical sciences ; Mice ; Mice, Inbred C57BL ; Neuropharmacology ; Pharmacology. Drug treatments ; Physiology ; Piperazines - pharmacology ; Piperazines - therapeutic use ; Psycholeptics: tranquillizer, neuroleptic ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Species Specificity</subject><ispartof>European journal of pharmacology, 2004-06, Vol.494 (1), p.45-53</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-ae439a0c7d9fdbf58fc3dc45a4400b7d66d0a5be64dd123a42805b3963d6eacb3</citedby><cites>FETCH-LOGICAL-c388t-ae439a0c7d9fdbf58fc3dc45a4400b7d66d0a5be64dd123a42805b3963d6eacb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014299904004443$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15854242$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15194450$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adriaan Bouwknecht, J</creatorcontrib><creatorcontrib>van der Gugten, Jan</creatorcontrib><creatorcontrib>Groenink, Lucianne</creatorcontrib><creatorcontrib>Olivier, Berend</creatorcontrib><creatorcontrib>Paylor, Richard E</creatorcontrib><title>Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Serotonin
1A (5-HT
1A) receptors are involved in anxiety. This study focuses on the role of genetic factors on the anxiety-related effects of 5-HT
1A receptor stimulation using both a within subject design. The effects of 5-HT
1A receptor activation were studied in high- and low-anxiety mice (129S6/SvEvTac (S6) and C57BL/6J (B6), respectively) in behavioral and physiological anxiety-related assays. These two strains were also selected because they are frequently used in gene-targeting studies. Mice were treated with the selective 5-HT
1A receptor agonist flesinoxan (0–0.3–1.0–3.0 mg/kg s.c.) and tested in either the open-field activity test, the light–dark exploration test, or the stress-induced hyperthermia paradigm. Flesinoxan unexpectedly increased anxiety, but also decreased activity on several behavioral measures in B6 mice. Flesinoxan produced only minimal effects in the behavioral tests in the high-anxiety S6 strain. In contrast, the physiological hyperthermia response showed anxiolytic-like effects of flesinoxan in both strains. Our data indicate that the role of 5-HT
1A receptor activation on anxiety-related responses is dependent on genetic background and selected paradigm used to assess anxiety. These findings indicate that it is critical to use a multi-level approach to develop mouse models for human diseases. In addition, the implication of such findings for studies on genetically modified mice is discussed.</description><subject>5-HT 1A receptor</subject><subject>Animal model</subject><subject>Animals</subject><subject>Anxiety</subject><subject>Anxiety - drug therapy</subject><subject>Anxiety - genetics</subject><subject>Behavior</subject><subject>Biological and medical sciences</subject><subject>Darkness</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Exploratory Behavior - drug effects</subject><subject>Exploratory Behavior - physiology</subject><subject>Flesinoxan</subject><subject>Lighting</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Physiology</subject><subject>Piperazines - pharmacology</subject><subject>Piperazines - therapeutic use</subject><subject>Psycholeptics: tranquillizer, neuroleptic</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Species Specificity</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF2LEzEUhoMobl39ByK50btp8z0TLwS37K5KwYtdr0MmObEpM5OatGX7701tQa-EwzkQnvNy8iD0lpI5JVQtNnPYbNc2zxkhYn4q3j5DM9q1uiEtZc_RjBAqGqa1vkKvStkQQqRm8iW6opJqISSZoXQDa3uIKdsB28nj7fpYYhrSz-jqy5j2BWr3MBQcUq7IU4Td8SOGEMDtCk4BhwFKnNKTnXCcMGX6QS0eDreHR-v-RC5le7NaqG94jA5eoxfBDgXeXOY1-nF3-7j80qy-339dfl41jnfdrrEguLbEtV4H3wfZBce9E9IKQUjfeqU8sbIHJbynjFvBOiJ7rhX3Cqzr-TX6cM7d5vRrD2VnxlgcDIOdoH7KtIwwqRStoDiDLqdSMgSzzXG0-WgoMSfRZmPOos1JtDkVb-vau0v-vh_B_126mK3A-wtgS1UZsp1cLP9wnRRMsMp9OnNVMRwiZFNchMmBj7kaNj7F_1_yG4LQnXs</recordid><startdate>20040621</startdate><enddate>20040621</enddate><creator>Adriaan Bouwknecht, J</creator><creator>van der Gugten, Jan</creator><creator>Groenink, Lucianne</creator><creator>Olivier, Berend</creator><creator>Paylor, Richard E</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040621</creationdate><title>Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice</title><author>Adriaan Bouwknecht, J ; van der Gugten, Jan ; Groenink, Lucianne ; Olivier, Berend ; Paylor, Richard E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-ae439a0c7d9fdbf58fc3dc45a4400b7d66d0a5be64dd123a42805b3963d6eacb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>5-HT 1A receptor</topic><topic>Animal model</topic><topic>Animals</topic><topic>Anxiety</topic><topic>Anxiety - drug therapy</topic><topic>Anxiety - genetics</topic><topic>Behavior</topic><topic>Biological and medical sciences</topic><topic>Darkness</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Exploratory Behavior - drug effects</topic><topic>Exploratory Behavior - physiology</topic><topic>Flesinoxan</topic><topic>Lighting</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Physiology</topic><topic>Piperazines - pharmacology</topic><topic>Piperazines - therapeutic use</topic><topic>Psycholeptics: tranquillizer, neuroleptic</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Species Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adriaan Bouwknecht, J</creatorcontrib><creatorcontrib>van der Gugten, Jan</creatorcontrib><creatorcontrib>Groenink, Lucianne</creatorcontrib><creatorcontrib>Olivier, Berend</creatorcontrib><creatorcontrib>Paylor, Richard E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adriaan Bouwknecht, J</au><au>van der Gugten, Jan</au><au>Groenink, Lucianne</au><au>Olivier, Berend</au><au>Paylor, Richard E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2004-06-21</date><risdate>2004</risdate><volume>494</volume><issue>1</issue><spage>45</spage><epage>53</epage><pages>45-53</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Serotonin
1A (5-HT
1A) receptors are involved in anxiety. This study focuses on the role of genetic factors on the anxiety-related effects of 5-HT
1A receptor stimulation using both a within subject design. The effects of 5-HT
1A receptor activation were studied in high- and low-anxiety mice (129S6/SvEvTac (S6) and C57BL/6J (B6), respectively) in behavioral and physiological anxiety-related assays. These two strains were also selected because they are frequently used in gene-targeting studies. Mice were treated with the selective 5-HT
1A receptor agonist flesinoxan (0–0.3–1.0–3.0 mg/kg s.c.) and tested in either the open-field activity test, the light–dark exploration test, or the stress-induced hyperthermia paradigm. Flesinoxan unexpectedly increased anxiety, but also decreased activity on several behavioral measures in B6 mice. Flesinoxan produced only minimal effects in the behavioral tests in the high-anxiety S6 strain. In contrast, the physiological hyperthermia response showed anxiolytic-like effects of flesinoxan in both strains. Our data indicate that the role of 5-HT
1A receptor activation on anxiety-related responses is dependent on genetic background and selected paradigm used to assess anxiety. These findings indicate that it is critical to use a multi-level approach to develop mouse models for human diseases. In addition, the implication of such findings for studies on genetically modified mice is discussed.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15194450</pmid><doi>10.1016/j.ejphar.2004.04.037</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2004-06, Vol.494 (1), p.45-53 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_72025661 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | 5-HT 1A receptor Animal model Animals Anxiety Anxiety - drug therapy Anxiety - genetics Behavior Biological and medical sciences Darkness Disease Models, Animal Dose-Response Relationship, Drug Exploratory Behavior - drug effects Exploratory Behavior - physiology Flesinoxan Lighting Male Medical sciences Mice Mice, Inbred C57BL Neuropharmacology Pharmacology. Drug treatments Physiology Piperazines - pharmacology Piperazines - therapeutic use Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Species Specificity |
title | Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T08%3A40%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Behavioral%20and%20physiological%20mouse%20models%20for%20anxiety:%20effects%20of%20flesinoxan%20in%20129S6/SvEvTac%20and%20C57BL/6J%20mice&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Adriaan%20Bouwknecht,%20J&rft.date=2004-06-21&rft.volume=494&rft.issue=1&rft.spage=45&rft.epage=53&rft.pages=45-53&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/j.ejphar.2004.04.037&rft_dat=%3Cproquest_cross%3E72025661%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72025661&rft_id=info:pmid/15194450&rft_els_id=S0014299904004443&rfr_iscdi=true |